Association of Anti-TNF with Decreased Survival in Steroid Refractory Ipilimumab and Anti-PD1-Treated Patients in the Dutch Melanoma Treatment Registry

Rik J. Verheijden, Anne M. May, Christian U. Blank, Maureen J. B. Aarts, Franchette W. P. J. van den Berkmortel, Alfonsus J. M. van den Eertwegh, Jan Willem B. de Groot, Marye J. Boers-Sonderen, Jacobus J. M. van der Hoeven, Geke A. Hospers, Djura Piersma, Rozemarijn S. van Rijn, Albert J. ten Tije, Astrid A. M. van der Veldt, Gerard Vreugdenhil, Michiel C. T. van Zeijl, Michel W. J. M. Wouters, John B. A. G. Haanen, Ellen Kapiteijn, Karijn P. M. Suijkerbuijk*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)2268-2274
Number of pages7
JournalClinical Cancer Research
Volume26
Issue number9
DOIs
Publication statusPublished - May 2020

Keywords

  • ADVERSE EVENTS
  • METASTATIC MELANOMA
  • COMBINED NIVOLUMAB
  • IMMUNE
  • CANCER
  • MONOTHERAPY
  • EFFICACY
  • SAFETY

Cite this

Verheijden, R. J., May, A. M., Blank, C. U., Aarts, M. J. B., van den Berkmortel, F. W. P. J., van den Eertwegh, A. J. M., de Groot, J. W. B., Boers-Sonderen, M. J., van der Hoeven, J. J. M., Hospers, G. A., Piersma, D., van Rijn, R. S., ten Tije, A. J., van der Veldt, A. A. M., Vreugdenhil, G., van Zeijl, M. C. T., Wouters, M. W. J. M., Haanen, J. B. A. G., Kapiteijn, E., & Suijkerbuijk, K. P. M. (2020). Association of Anti-TNF with Decreased Survival in Steroid Refractory Ipilimumab and Anti-PD1-Treated Patients in the Dutch Melanoma Treatment Registry. Clinical Cancer Research, 26(9), 2268-2274. https://doi.org/10.1158/1078-0432.CCR-19-3322